Dutch stem cell biotech Neuroplast appoints TiGenix founder Frank Luyten and Sanquin director Pieter De Geus to its supervisory board

- Appointments instrumental in the further development of advanced cell-based therapies for inflammation-driven neurological disorders GELEEN, Netherlands, Oct. 21, 2021 /PRNewswire/ --

Related Keywords

Netherlands ,Geleen ,Limburg ,Amsterdam ,Noord Holland ,Dutch ,Gil Beyen ,Erik Wolters ,Wim Brouwer ,Marcel Kloosterman ,Frank Luyten ,Kostenloser Wertpapierhandel ,Prnewswire Neuroplast ,Sasja Verhoog ,Dutch Sanquin Health Solutions ,Sanquin Health Solutions ,Sanquin Foundation ,Nasdaq ,Pieter De Geus ,Managing Director ,Traumatic Spinal Cord ,Belgian Tigenix ,Professor Emeritus ,Advanced Therapy Medicinal Products ,Traumatic Spinal Cord Injury ,Johannes De Munter ,Lumana Invest ,Brightlands Chemelot Campus ,Spring Lifesciences Communication ,Item ,Fell ,Biotech ,Neuroplast ,Ppoints ,Igenix ,Founder ,Rank ,Buyten ,Lanquin ,Director ,Mieter ,Eus ,Upervisory ,Board ,